Published in Oncogene on March 15, 2010
NF-κB and cancer: a paradigm of Yin-Yang. Am J Cancer Res (2010) 1.08
microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Oncogene (2011) 1.06
Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Cancer Res (2011) 0.98
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate (2011) 0.97
Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer (2015) 0.96
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol Oncol (2012) 0.94
Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis (2010) 0.91
NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age. Expert Rev Neurother (2014) 0.91
Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics (2012) 0.89
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers. Carcinogenesis (2012) 0.88
14-3-3ζ interacts with stat3 and regulates its constitutive activation in multiple myeloma cells. PLoS One (2012) 0.88
A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells. Oncotarget (2016) 0.85
Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells. Clin Exp Metastasis (2011) 0.85
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. J Neurosci (2016) 0.83
Protein Kinase C-ε Promotes EMT in Breast Cancer. Breast Cancer (Auckl) (2014) 0.82
FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver. Cell Commun Signal (2014) 0.82
Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunol (2016) 0.82
The Multifunctional Protein Kinase C-ε in Cancer Development and Progression. Cancers (Basel) (2014) 0.81
Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε. J Biol Chem (2012) 0.81
Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer. Oncotarget (2015) 0.80
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Cancer Prev Res (Phila) (2015) 0.80
INPP4B suppresses prostate cancer cell invasion. Cell Commun Signal (2014) 0.79
Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis. PLoS One (2015) 0.78
Targeting protein kinase C subtypes in pancreatic cancer. Expert Rev Anticancer Ther (2015) 0.78
Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2. Mol Carcinog (2011) 0.77
Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells. Mol Cancer Ther (2016) 0.76
Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. Mol Neurobiol (2016) 0.75
Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals. Carcinogenesis (2015) 0.75
STAT3 Undergoes Acetylation-dependent Mitochondrial Translocation to Regulate Pyruvate Metabolism. Sci Rep (2016) 0.75
STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma. Int J Clin Exp Pathol (2014) 0.75
Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma. Hepatology (2016) 0.75
Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation. Oncol Lett (2017) 0.75
Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer. Oncotarget (2016) 0.75
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via SHP-1-STAT3-survivin cascade. Br J Pharmacol (2017) 0.75
The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. Oncotarget (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
The extended protein kinase C superfamily. Biochem J (1998) 5.84
Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer (2007) 5.71
The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer (2005) 5.07
Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev (2001) 4.38
Serine phosphorylation of STATs. Oncogene (2000) 4.21
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
Roles of STAT3 defined by tissue-specific gene targeting. Oncogene (2000) 2.71
Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev (2005) 1.93
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res (2005) 1.82
Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A (2006) 1.77
Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets (2006) 1.63
Protein kinase Cepsilon makes the life and death decision. Cell Signal (2007) 1.57
Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res (2007) 1.56
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res (2005) 1.41
Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem (1999) 1.41
Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res (2002) 1.39
Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells. Cancer Res (2005) 1.33
Opposing actions of STAT-1 and STAT-3. Growth Factors (2005) 1.33
Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog (2000) 1.32
Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res (2007) 1.31
Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res (2005) 1.27
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol (2004) 1.25
Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res (2006) 1.24
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res (2005) 1.21
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res (2004) 1.15
Novel RING E3 ubiquitin ligases in breast cancer. Neoplasia (2006) 1.14
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res (2000) 1.13
Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells. Oncogene (2004) 1.13
Protein kinase Cepsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer. Mol Carcinog (2007) 1.12
Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res (2007) 1.08
MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J Biol Chem (2001) 1.07
Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase. J Biol Chem (2007) 1.07
A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun (2004) 1.03
Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3. J Biol Chem (2003) 1.02
The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis (2004) 1.02
Modulating protein kinase C signal transduction. Adv Pharmacol (1998) 1.01
Targeting the STAT pathway in head and neck cancer: recent advances and future prospects. Curr Cancer Drug Targets (2004) 0.97
Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism. Photochem Photobiol (2005) 0.91
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene (2001) 2.08
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene (2007) 1.57
Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res (1979) 1.52
Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem (1988) 1.50
Pulmonary function profile in patients with benign goiters without symptoms of respiratory compromise and the early effect of thyroidectomy. J Postgrad Med (2008) 1.48
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells. Oncogene (2008) 1.33
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res (1978) 1.27
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res (1977) 1.22
The rate of activation by calmodulin of isoform 4 of the plasma membrane Ca(2+) pump is slow and is changed by alternative splicing. J Biol Chem (1999) 1.21
The Ca2+ affinity of the plasma membrane Ca2+ pump is controlled by alternative splicing. J Biol Chem (1994) 1.20
A highly active 120-kDa truncated mutant of the plasma membrane Ca2+ pump. J Biol Chem (1993) 1.18
Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J (1996) 1.17
Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India (2003) 1.15
Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.15
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res (2000) 1.13
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia (2010) 1.13
A pilot study of same day sputum smear examination, its feasibility and usefulness in diagnosis of pulmonary TB. Indian J Tuberc (2011) 1.12
Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1999) 1.11
Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res (1982) 1.08
Protein kinase C activates the plasma membrane Ca2+ pump isoform 4b by phosphorylation of an inhibitory region downstream of the calmodulin-binding domain. J Biol Chem (1996) 1.07
Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer (2001) 1.07
Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol (1989) 1.06
Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. World J Surg (2015) 1.05
Uptake of insulin by plasmalemma and Golgi subcellular fractions of rat liver. J Biol Chem (1980) 1.05
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect (2004) 1.02
Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency. World J Surg (2008) 1.02
Protein kinase C phosphorylates the "a" forms of plasma membrane Ca2+ pump isoforms 2 and 3 and prevents binding of calmodulin. J Biol Chem (1997) 1.02
Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol Pharmacol (1999) 1.00
Intracellular hormone receptors: evidence for insulin and lactogen receptors in a unique vesicle sedimenting in lysosome fractions of rat liver. Proc Natl Acad Sci U S A (1981) 1.00
Overexpression of the erythrocyte plasma membrane Ca2+ pump in COS-1 cells. Biochem J (1992) 1.00
Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg (2010) 1.00
Antibodies directed toward human erythrocyte Ca2+-ATPase: effect on enzyme function and immunoreactivity of Ca2+-ATPases from other sources. Arch Biochem Biophys (1982) 0.98
Functional impression technique for an ocular prosthesis. J Indian Prosthodont Soc (2011) 0.98
Cervical lymphadenopathy: scrofula revisited. J Laryngol Otol (2008) 0.98
Molecular properties of calcium-pumping ATPase from human erythrocytes. Biochemistry (1982) 0.97
Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg (2007) 0.97
Fine needle aspiration cytology of salivary gland lesions. J Oral Pathol Med (1994) 0.96
Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res (1987) 0.96
Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res (1987) 0.95
The housefly (Musca domestica) as a carrier of pathogenic microorganisms in a hospital environment. J Hosp Infect (1992) 0.95
Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Biochem Biophys Res Commun (1982) 0.94
Isolation of phytase-producing bacteria from Himalayan soils and their effect on growth and phosphorus uptake of Indian mustard (Brassica juncea). World J Microbiol Biotechnol (2013) 0.94
Calcium pump epitopes in placental trophoblast basal plasma membranes. Am J Physiol (1989) 0.93
Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Res (1979) 0.93
Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry (1991) 0.91
A high affinity Ca2+-stimulated and Mg2+-dependent ATPase in rat corpus luteum plasma membrane fractions. J Biol Chem (1981) 0.91
Purification of the Ca2+-and Mg2+-requiring ATPase from rat brain synaptic plasma membrane. Biochem J (1982) 0.91
Characterization of membrane calcium pumps by simultaneous immunoblotting and 32P radiography. Biochim Biophys Acta (1988) 0.90
Clinicopathological profile, airway management, and outcome in huge multinodular goiters: an institutional experience from an endemic goiter region. World J Surg (2012) 0.90
Polypeptide hormones: intracellular receptors and internalization. Recent Prog Horm Res (1981) 0.89
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst (1993) 0.89
Myasthenia gravis in young. Indian Pediatr (1986) 0.89
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (1998) 0.89
The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides. J Org Chem (1977) 0.88
Plasma membrane Ca(2+) pump isoform 3f is weakly stimulated by calmodulin. J Biol Chem (2000) 0.87
Effects of retinoic acid and juvenile hormone on the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1978) 0.87
Localization of adenosine o',5'-monophosphate in mouse epidermis by immunofluorescence. J Invest Dermatol (1976) 0.87
Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine (2009) 0.86
Effects of Fasciola gigantica infection on growth and nutrient utilisation of buffalo calves. Vet Rec (1999) 0.86
Human cutaneous myiasis due to mixed infestation in a drug addict. Ann Trop Med Parasitol (1991) 0.85
Effect of colchicine on the uptake of prolactin and insulin into Golgi fractions of rat liver. J Cell Biol (1982) 0.85
Primary experimental infection of riverine buffaloes with Fasciola gigantica. Vet Parasitol (1999) 0.85
The induction of ornithine decarboxylase activity and its control in mouse skin epidermis. Adv Enzyme Regul (1978) 0.85
Plasma membrane Ca2+ pumps. Ann N Y Acad Sci (1997) 0.84
Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem Biophys Res Commun (1977) 0.84
Vertebroplasty in osteoporotic spine fractures: a quality of life assessment. Can J Neurol Sci (2005) 0.84
Ultraviolet light induces epidermal ornithine decarboxylase activity. J Invest Dermatol (1978) 0.84
Letter: Novel maytansinoids. Naturally occurring and synthetic antileukemic esters of maytansinol. J Am Chem Soc (1975) 0.83
Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Cancer Res (1983) 0.83
Formation of alpha-1,2-mannosyl-mannose by an enzyme preparation from rabbit liver. J Biol Chem (1977) 0.83
Comparative study of wear resistance of acrylic teeth produced in India. J Indian Dent Assoc (1985) 0.83
A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (1998) 0.83
Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1986) 0.82
Two Ca2+-requiring p-nitrophenylphosphatase activities of the highly purified Ca2+-pumping adenosinetriphosphatase of human erythrocyte membranes, one requiring calmodulin and the other ATP. Biochemistry (1984) 0.82
Cellular and segmental distribution of Ca2(+)-pump epitopes in rat intestine. Pflugers Arch (1990) 0.82
The effect of benzo(alpha)pyrene on the basal and isoproterenol-stimulated levels of cyclic adenosine 3',5'-monophosphate in mouse epidermis. Cancer Res (1974) 0.82
Sensitization with anti-inflammatory BmAFI of Brugia malayi allows L3 development in the hostile peritoneal cavity of Mastomys coucha. Acta Trop (2011) 0.82
Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis. Cancer Res (1976) 0.81
Echinococcosis involving the breast: diagnosis by fine needle aspiration cytology. Indian J Pathol Microbiol (1996) 0.81
Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid. Cancer Res (1980) 0.81
Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana. J Ethnopharmacol (1994) 0.81
Prevalence of XDR TB cases--a retrospective study from a tertiary care TB hospital. Indian J Tuberc (2011) 0.81
Hypesthetic-ataxic-hemiparesis in thalamic hemorrhage. Stroke (1986) 0.81
Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders. World J Surg (2010) 0.81
Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis. Carcinog Compr Surv (1982) 0.81
Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. Cancer Epidemiol Biomarkers Prev (2001) 0.81
Functional expression and characterization of the mouse epitope tag-protein kinase C isoforms, alpha, beta I, beta II, gamma, delta and epsilon. Gene (1996) 0.81
Retinoic acid nuclear receptors and tumor promotion: decreased expression of retinoic acid nuclear receptors by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis (1994) 0.80
Co-localization of erythrocyte Ca++-Mg++ ATPase and vitamin D-dependent 28-kDa-calcium binding protein. Kidney Int (1988) 0.80
Geriatric health: need to make it an essential element of primary health care. Indian J Public Health (2011) 0.80
Finger ulceration in a healthcare professional. Ann Afr Med (2010) 0.80